m6A-centered Crosstalk Information
Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
| Crosstalk ID |
M6ACROT00533
|
[1], [2], [3], [4], [5], [6] | |||
: m6A sites
Indirect
Enhancement
RNA modification
MIR26A1
MIR26A1
ADAR
Methylation
: modification sites
|
|||||
| m6A Modification: | |||||
|---|---|---|---|---|---|
| m6A Regulator | Methyltransferase-like 3 (METTL3) | WRITER | |||
| m6A Target | Metastasis associated lung adenocarcinoma transcript 1 (MALAT1) | ||||
| Epigenetic Regulation that have Cross-talk with This m6A Modification: | |||||
| Epigenetic Regulation Type | RNA modification (RNAMod) >> Adenosine-to-Inosine editing (A-to-I) | ||||
| Epigenetic Regulator | Interferon-inducible protein 4 (ADAR1) | WRITER | View Details | ||
| Regulated Target | MicroRNA 26a-1 (MIR26A1) | View Details | |||
| Crosstalk Relationship | m6A → A-to-I | Enhancement | |||
| Crosstalk Mechanism | m6A modification indirectly impacts RNA modification through downstream signaling pathways | ||||
| Crosstalk Summary | METTL3 interacts with Metastasis associated lung adenocarcinoma transcript 1 (MALAT1), increasing its m6A level and promoting its physical interaction with MicroRNA 26a-1 (MIR26A1), which was regulated by ADAR1-mediated A-to-I modification. | ||||
In-vitro Model |
MGG8 | Glioblastoma | Homo sapiens | CVCL_D1H4 | |
| HK2 | Normal | Acipenser baerii | CVCL_YE28 | ||
| U-87MG ATCC | Glioblastoma | Homo sapiens | CVCL_0022 | ||
| MCF-7 | Invasive breast carcinoma | Homo sapiens | CVCL_0031 | ||
| K-562 | Chronic myelogenous leukemia | Homo sapiens | CVCL_0004 | ||
References
: m6A sites
: modification sites